Literature DB >> 32047913

Effect and mechanism of YB-1 knockdown on glioma cell growth, migration, and apoptosis.

Huilin Gong1, Shan Gao2, Chenghuan Yu3, Meihe Li2, Ping Liu4, Guanjun Zhang1, Jinning Song5, Jin Zheng2.   

Abstract

Y-box binding protein 1 (YB-1) is manifested as its involvement in cell proliferation and differentiation and malignant cell transformation. Overexpression of YB-1 is associated with glioma progression and patient survival. The aim of this study is to investigate the influence of YB-1 knockdown on glioma cell progression and reveal the mechanisms of YB-1 knockdown on glioma cell growth, migration, and apoptosis. It was found that the knockdown of YB-1 decreased the mRNA and protein levels of YB-1 in U251 glioma cells. The knockdown of YB-1 significantly inhibited cell proliferation, colony formation, and migration in vitro and tumor growth in vivo. Proteome and phosphoproteome data revealed that YB-1 is involved in glioma progression through regulating the expression and phosphorylation of major proteins involved in cell cycle, adhesion, and apoptosis. The main regulated proteins included CCNB1, CCNDBP1, CDK2, CDK3, ADGRG1, CDH-2, MMP14, AIFM1, HO-1, and BAX. Furthermore, it was also found that YB-1 knockdown is associated with the hypo-phosphorylation of ErbB, mTOR, HIF-1, cGMP-PKG, and insulin signaling pathways, and proteoglycans in cancer. Our findings indicated that YB-1 plays a key role in glioma progression in multiple ways, including regulating the expression and phosphorylation of major proteins associated with cell cycle, adhesion, and apoptosis.
© The Author(s) 2020. Published by Oxford University Press on behalf of the Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  YB-1; apoptosis; glioma; knockdown; migration; proliferation

Year:  2020        PMID: 32047913     DOI: 10.1093/abbs/gmz161

Source DB:  PubMed          Journal:  Acta Biochim Biophys Sin (Shanghai)        ISSN: 1672-9145            Impact factor:   3.848


  4 in total

1.  Upregulated YB-1 protein promotes glioblastoma growth through a YB-1/CCT4/mLST8/mTOR pathway.

Authors:  Jin-Zhu Wang; Hong Zhu; Pu You; Hui Liu; Wei-Kang Wang; Xiaojuan Fan; Yun Yang; Keren Xu; Yingfeng Zhu; Qunyi Li; Ping Wu; Chao Peng; Catherine Cl Wong; Kaicheng Li; Yufeng Shi; Nu Zhang; Xiuxing Wang; Rong Zeng; Ying Huang; Liusong Yang; Zefeng Wang; Jingyi Hui
Journal:  J Clin Invest       Date:  2022-04-15       Impact factor: 19.456

2.  Cyclin D1 Binding Protein 1 Responds to DNA Damage through the ATM-CHK2 Pathway.

Authors:  Yusuke Niwa; Kenya Kamimura; Kohei Ogawa; Chiyumi Oda; Yuto Tanaka; Ryoko Horigome; Masato Ohtsuka; Hiromi Miura; Koichi Fujisawa; Naoki Yamamoto; Taro Takami; Shujiro Okuda; Masayoshi Ko; Takashi Owaki; Atsushi Kimura; Osamu Shibata; Shinichi Morita; Norihiro Sakai; Hiroyuki Abe; Takeshi Yokoo; Akira Sakamaki; Hiroteru Kamimura; Shuji Terai
Journal:  J Clin Med       Date:  2022-02-06       Impact factor: 4.241

3.  Development and Validation of Lactate Metabolism-Related lncRNA Signature as a Prognostic Model for Lung Adenocarcinoma.

Authors:  Shijie Mai; Liping Liang; Genghui Mai; Xiguang Liu; Dingwei Diao; Ruijun Cai; Le Liu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-29       Impact factor: 5.555

4.  Role of hypoxia inducible factor-1 in cancer stem cells (Review).

Authors:  Qi Zhang; Zhenzhen Han; Yanbo Zhu; Jingcheng Chen; Wei Li
Journal:  Mol Med Rep       Date:  2020-11-12       Impact factor: 2.952

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.